Skip to content

Chlorambucil

Leukeran (chlorambucil) is a small molecule pharmaceutical. Chlorambucil was first approved as Leukeran on 1982-01-01. It is used to treat b-cell chronic lymphocytic leukemia, breast neoplasms, choriocarcinoma, hodgkin disease, and non-hodgkin lymphoma amongst others in the USA.
Trade Name Leukeran
Common Name Chlorambucil
Indication b-cell chronic lymphocytic leukemia, breast neoplasms, choriocarcinoma, hodgkin disease, non-hodgkin lymphoma, ovarian neoplasms, testicular neoplasms, thrombocytosis, waldenstrom macroglobulinemia
Drug Class
Chlorambucil
Get full access now